You are here

OPTICAL ASSAY FOR OXYGEN IN DIAGNOSTIC TESTS

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 13959
Amount: $49,935.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1990
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
21806 Ne 1st
Redmond, WA 98053
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 David L Putnam
 (206) 392-4895
Business Contact
Phone: () -
Research Institution
N/A
Abstract

THE LONG-TERM OBJECTIVE IS TO DEVELOP AN INSTRUMENT AND ASSAY SYSTEM FOR OPTICAL MEASUREMENT OF OXYGEN IN VITRO THATWILL BE USED FOR DIAGNOSTIC TESTS INVOLVING REACTANTS THAT CONSUME OXYGEN. THE IMMEDIATE APPLICATION IS FOR CHOLESTEROL ANALYSIS USING AN OXIDATIVE ENZYME SYSTEM. THE CONCEPT IS THAT OXYGEN UTILIZATION IS DIRECTLY TIED TO SUBSTRATE TURNOVER; THEREFORE, DETERMINATION OF THE CHANGE IN THE AMOUNT OF OXYGEN IN A SAMPLE FLUID CAN BE AN ACCURATE MEASURE OF THE SUBSTRATE CONCENTRATION. PRELIMINARY RESULTS INDICATE THAT THE OPTICAL SENSING APPROACH HAS PROMISE AND COULD BE THE BASIS FOR A SYSTEM THAT CONVENIENTLY PROCESSES MULTIPLE SAMPLES. THE AIM OF PHASE I IS TO ASSESS THE RANGE, ACCURACY, AND RELIABILITY OFTHE APPROACH IN ORDER TO ESTABLISH ITS FEASIBILITY FOR CHOLESTEROL ANALYSIS. CHOLESTEROL SAMPLES OF KNOWN VALUES WILL BE REACTED WITH CONVENTIONAL ENZYME REAGENT, AND THE CHANGE IN OXYGEN CONTENT OF THE SAMPLE WILL BE TRACKED WITH FIBEROPTIC OXYGEN SENSORS. THE DATA WILL BE COMPARED AND CONTRASTED TO THE KNOWN CHOLESTEROL LEVELS AS WELL AS THE RESULTS OF OTHER CONVENTIONAL ASSAY METHODS.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government